Beijing University of Chinese Medicine, Beijing 100029, China.
Evid Based Complement Alternat Med. 2011;2011:408650. doi: 10.1155/2011/408650. Epub 2011 Aug 21.
Coronary heart disease (CHD) is still the leading cause of death for adults worldwide. Traditional Chinese medicine (TCM) has a history of 1000 years fighting against the disease and provides a complementary and alternative treatment to it. Syndrome is the core of TCM diagnosis and it is traditionally diagnosed based on macroscopic symptoms as well as tongue and pulse recognitions of patients. Establishment of the diagnosis method in the microcosmic level is an urgent and major problem in TCM. The aim of this study was to establish characteristic diagnosis pattern for CHD with Qi deficiency syndrome (QDS). Thirty-four biological parameters were detected in 52 patients having unstable angina (UA) with or without QDS. Then, we presented a novel data mining method, t-test-based Adaboost algorithm, to establish highest prediction accuracy with the least number of biological parameters for UA with QDS. We gained a pattern composed of five biological parameters that distinguishes UA with QDS patients from non-QDS patients. The diagnosis accuracy of the patterns could reach 84.5% based on a 3-fold cross validation technique. Moreover, we included 85 UA cases collected from hospitals located in the north and south of China to further verify the association between the pattern and QDS. The classification accuracy is 83.5%, which keeps consistent with the accuracy obtained by the cross-validation technique. The association between a symptom and the five biological parameters was established by the data mining method and it reached an accuracy of ∼80%. These results showed that the t-test-based Adaboost algorithm might be a powerful technique for diagnosing syndrome in TCM in the context of CHD.
冠心病(CHD)仍然是全球成年人的主要死因。中医药(TCM)已有 1000 年的历史,可对抗这种疾病,并提供补充和替代治疗。证候是中医诊断的核心,传统上是根据患者的宏观症状以及舌诊和脉诊进行诊断。在微观水平上建立诊断方法是中医的一个紧迫和重大问题。本研究的目的是建立气虚证(QDS)冠心病的特征诊断模式。对 52 例不稳定型心绞痛(UA)患者(有或无 QDS)检测了 34 个生物学参数。然后,我们提出了一种新的数据挖掘方法,基于 t 检验的 Adaboost 算法,以用最少的生物学参数建立 UA 与 QDS 的最高预测准确性。我们获得了一个由五个生物学参数组成的模式,可将 UA 与 QDS 患者与非 QDS 患者区分开来。基于三折交叉验证技术,该模式的诊断准确率可达 84.5%。此外,我们纳入了来自中国南北医院的 85 例 UA 病例,以进一步验证该模式与 QDS 的关联。分类准确率为 83.5%,与交叉验证技术获得的准确率一致。数据挖掘方法建立了症状与五个生物学参数之间的关联,其准确率达到了约 80%。这些结果表明,基于 t 检验的 Adaboost 算法可能是 CHD 中医证候诊断的一种强大技术。